• Quantifying the Average Human Genome

    Bio-IT World | Mining two mega-datasets totaling over 900,000 sequenced genomes, researchers in the UK produced the broadest look yet at what a typical human genome contains and found that “normal” can look alarming on paper. “Variation is the norm,” they found. The work was published October in Genome Medicine.

    Nov 3, 2026

  • Quantifying the Average Human Genome

    Bio-IT World | Mining two mega-datasets totaling over 900,000 sequenced genomes, researchers in the UK produced the broadest look yet at what a typical human genome contains and found that “normal” can look alarming on paper. “Variation is the norm,” they found. The work was published October in Genome Medicine.

    Nov 3, 2026

  • Regulatory Affairs Is the Connective Tissue Pharma’s AI Strategy Is Missing

    Bio-IT World | Every major pharma organization I’ve come across in recent years has its own version of the same AI-based ambition. It is looking to use the technology to compress the R&D timeline, reduce late-stage attrition, and make regulatory submissions faster and inspections less tense. And yet, almost without exception, progress will stall because the product data foundations are flawed.

    Oct 29, 2026

  • Follow the Money: OMass Raises Series C, Pathos AI Drug Development, Owkin Alums Launch Rivercell

    Bio-IT World | Matchpoint Therapeutics closes $150M Series B for oral autoimmune drugs; Soufflé Therapeutics raises $135M to take siRNA beyond the liver; WhiteLab Genomics adds $26M for AI-designed gene therapy delivery; and more.

    Oct 28, 2026

  • ParkourSC Acquires Quartic, PacBio Partners with Verily, CAS Data Arrives in Microsoft Copilot

    Bio-IT World | Carterra and AstraZeneca collaborate on lab-in-the-loop drug discovery; Ultima Genomics is selected for an 80,000-sample UK Biobank immune profiling study; Hansa Biopharma taps Cradle for AI protein design; Genedata adds NVIDIA protein design models to its discovery workflows; Dotmatics reaches Databricks Gold status; new products from Revvity, Benchling, and Nabsys; and more.

    Oct 27, 2026

  • Innovating at Speed in an Underrated Drug-Making Process

    Bio-IT World | Novartis recently leapt to the front of the pack with a self-service platform for digitalizing chemical manufacturing controls (CMC) built on a new-to-market enterprise solution from Genedata that leverages artificial intelligence (AI) agents providing a “Gemini-like” experience to users. The collaborative feat seamlessly connects data and workflows across modalities and sites, significantly boosting operational efficiency and submission timelines for Novartis. It also earned the company an Innovative Practices Award at the Bio-IT World Conference and Expo earlier this year in Boston.

    Oct 22, 2026